Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Jyong Biotech Ltd. (MENS) had Tangible Shareholders Equity of $-24.91M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$15.54M |
|
$4.83M |
|
$6.92M |
|
$20.78M |
|
$34.81M |
|
$10.16M |
|
$10.85M |
|
$45.68M |
|
$-24.91M |
|
|
Tangible Shareholders Equity |
$-24.91M |
$-24.91M |
|
-- |
|
| Cash Flow Statement Financials | |
$-3.04M |
|
$-13.51M |
|
$17.63M |
|
$0.10M |
|
$1.18M |
|
$1.08M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|